XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Oct. 31, 2020
Apr. 30, 2020
Current Assets:    
Cash and cash equivalents $ 5,759 $ 4,365
Restricted cash 481 850
Receivables, less allowance; $705; $606, on each respective date 33,753 28,062
Inventories 16,124 15,330
Income tax receivable 3,220 2,717
Prepaid expenses and other current assets 3,053 2,907
Total Current Assets 62,390 54,231
Property, plant and equipment, at cost 59,007 57,859
Accumulated depreciation (42,789) (41,587)
Net Property, Plant and Equipment 16,218 16,272
Right of use assets 9,157 9,312
Deferred income taxes 0 336
Other assets 3,597 3,778
Total Assets 91,362 83,929
Current Liabilities:    
Short-term borrowings 7,592 4,719
Current portion of capital lease liability 20 19
Current portion of operating lease liabilities 1,281 1,282
Accounts payable 17,258 13,114
Employee compensation and amounts withheld 3,374 4,159
Deferred revenue 2,768 2,508
Other accrued expenses 1,567 1,259
Total Current Liabilities 33,860 27,060
Long-term portion of capital lease liability 102 113
Long-term portion of operating lease liabilities 7,796 7,780
Accrued pension and deferred compensation costs 9,931 9,303
Deferred income taxes 323 401
Other non-current liabilities 1,281 569
Total Liabilities 53,293 45,226
Commitments and Contingencies
Stockholders’ Equity:    
Common stock, $2.50 par value, Authorized – 5,000 shares; Issued – 2,762 shares; 2,754 shares; – Outstanding – 2,759 shares; 2,751 shares, on each respective date 6,905 6,885
Additional paid-in-capital 3,581 3,360
Retained earnings 37,043 37,821
Accumulated other comprehensive loss (9,646) (9,598)
Common stock in treasury, at cost, 3 shares, on each date (53) (53)
Total Kewaunee Scientific Corporation Stockholders’ Equity 37,830 38,415
Noncontrolling interest 239 288
Total Stockholders’ Equity 38,069 38,703
Total Liabilities and Stockholders’ Equity $ 91,362 $ 83,929